ArticleCureus2026
Atypical Sjögren-Like Presentation as a Paraneoplastic Manifestation of Metastatic Parotid Adenocarcinoma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paraneoplastic Sjögren-like syndrome is a rare extraglandular manifestation of occult malignancy that can closely mimic primary autoimmune disease, leading to delayed diagnosis of the underlying neoplasm. While most reported cases are associated with hematological malignancies, its occurrence in the context of solid tumors, particularly salivary gland carcinomas, is exceptionally rare and poorly characterized. We report a 43-year-old male presenting with progressive dyspnea, constitutional symptoms, and severe polyserositis, initially suggestive of primary Sjögren's syndrome (SS) based on objective sicca findings, including severely reduced lacrimal secretion on the Schirmer test and clinically observed asialia, in conjunction with positive anti-SSA antibodies. Imaging showed persistent pulmonary lesions and pleural effusions, while bronchoalveolar lavage revealed markedly elevated galactomannan levels, suggesting probable pulmonary aspergillosis. Despite immunosuppressive therapy, no clinical improvement was observed. Further evaluation, including surgical biopsy, demonstrated metastatic adenocarcinoma of probable salivary gland origin. The final diagnosis was stage IV parotid adenocarcinoma with pulmonary metastases and paraneoplastic Sjögren-like syndrome. The patient received one cycle of chemotherapy but subsequently deteriorated and died. Paraneoplastic Sjögren-like syndrome is exceptionally rare and characterized by heterogeneous clinical presentations, often lacking classic histopathological findings. Red flags such as rapid progression, systemic involvement, and poor response to standard therapy should prompt evaluation for occult malignancy. This case highlights the importance of recognizing atypical Sjögren-like presentations as a probable paraneoplastic phenomenon. Early identification of warning signs may facilitate timely diagnosis of underlying malignancy and impact clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.